Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

620 ARTÍCULOS , VIENDO DEL 106 AL 120

β-Lactolin Enhances Neural Activity, Indicated by Event-Related P300 Amplitude, in Healthy Adults: A Randomized Controlled Trial

Kanatome A, Ano Y, Shinagawa K, Ide Y, Shibata M, Umeda S.

J Alzheimers Dis. 2021;81(2):787-796. doi: 10.3233/JAD-201413.

A Precision Medicine Approach to Treating Alzheimer's Disease Using Rosiglitazone Therapy: A Biomarker Analysis of the REFLECT Trials

O'Bryant SE, Zhang F, Petersen M, Johnson L, Hall J, Rissman RA.

J Alzheimers Dis. 2021;81(2):557-568. doi: 10.3233/JAD-201610.

Multitarget Directed Ligand Approaches for Alzheimer's Disease: A Comprehensive Review

Ramalakshmi N, R S R, C N N.

Mini Rev Med Chem. 2021;21(16):2361-2388. doi: 10.2174/1389557521666210405161205.

TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation

Magno L, Bunney TD, Mead E, Svensson F, Bictash MN.

Mol Neurodegener. 2021 Apr 6;16(1):22. doi: 10.1186/s13024-021-00436-5.

Aducanumab for Alzheimer's disease: The never-ending story that nurses should know

Petch J, Bressington D.

Nurs Open. 2021 Jul;8(4):1524-1526. doi: 10.1002/nop2.878. Epub 2021 Apr 7.

Natural products as pharmacological modulators of mitochondrial dysfunctions for the treatments of Alzheimer's disease: A comprehensive review

Jin X, Guo JL, Wang L, Zhong X, Yao WF, Gao H, Liu MY.

Eur J Med Chem. 2021 Jun 5;218:113401. doi: 10.1016/j.ejmech.2021.113401. Epub 2021 Mar 27.

Stressed mitochondria: A target to intrude alzheimer's disease

Sharma VK, Singh TG, Mehta V.

Mitochondrion. 2021 Jul;59:48-57. doi: 10.1016/j.mito.2021.04.004. Epub 2021 Apr 8.

Epigenetic regulation in Alzheimer's disease: is it a potential therapeutic target?

Coppedè F.

Expert Opin Ther Targets. 2021 Apr;25(4):283-298. doi: 10.1080/14728222.2021.1916469. Epub 2021 May 13.

Repurposing Licensed Drugs for Use Against Alzheimer's Disease

Norins LC.

J Alzheimers Dis. 2021;81(3):921-932. doi: 10.3233/JAD-210080.

The brain as an insulin-sensitive metabolic organ

Milstein JL, Ferris HA.

Mol Metab. 2021 Oct;52:101234. doi: 10.1016/j.molmet.2021.101234. Epub 2021 Apr 15.

Structure, Function and Modulation of Striatal-enriched Protein Tyrosine Phosphatase (STEP)

Liang X, Hou X, Fang H.

Curr Med Chem. 2021;28(37):7714-7728. doi: 10.2174/0929867328666210412123304.

Cytokine signaling convergence regulates the microglial state transition in Alzheimer's disease

Lau SF, Fu AKY, Ip NY.

Cell Mol Life Sci. 2021 May;78(10):4703-4712. doi: 10.1007/s00018-021-03810-0. Epub 2021 Apr 13.

Cerebrovascular Pathology and Responsiveness to Treatment in Alzheimer's Disease: A Systematic Review

Bentham C, De Marco M, Venneri A.

Curr Alzheimer Res. 2021;18(2):103-124. doi: 10.2174/1567205018666210414121227.

Serotonin 2 Receptors, Agomelatine, and Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease

Li HH, Yao XY, Tao S, Sun X, Li PP, Li XX, Liu ZL, Ren C.

Behav Neurol. 2021 Mar 31;2021:5533827. doi: 10.1155/2021/5533827. eCollection 2021.

Development of grape polyphenols as multi-targeting strategies for Alzheimer's disease

El Gaamouch F, Liu K, Lin HY, Wu C, Wang J.

Neurochem Int. 2021 Jul;147:105046. doi: 10.1016/j.neuint.2021.105046. Epub 2021 Apr 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias